Literature DB >> 30950157

CeVO4 Nanozymes Catalyze the Reduction of Dioxygen to Water without Releasing Partially Reduced Oxygen Species.

Namrata Singh1,2, Govindasamy Mugesh1.   

Abstract

In this study, we report a remarkably active CeVO4 nanozyme that functionally mimics cytochrome c oxidase (CcO), the terminal enzyme in the respiratory electron transport chain, by catalyzing a four-electron reduction of dioxygen to water. The nanozyme catalyzes the reaction by using cytochrome c (Cyt c), the biological electron donor for CcO, at physiologically relevant pH. The CcO activity of the CeVO4 nanozymes depends on the relative ratio of surface Ce3+ /Ce4+ ions, the presence of V5+ and the surface-Cyt c interactions. The complete reduction of oxygen to water takes place without release of any partially reduced oxygen species (PROS) such as superoxide, peroxide and hydroxyl radicals.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cytochrome c oxidase; dioxygen reduction; nanozymes; oxidative stress; superoxide dismutase

Year:  2019        PMID: 30950157     DOI: 10.1002/anie.201903427

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  3 in total

1.  Photoluminescence and Energy Transfer in Double- and Triple-Lanthanide-Doped YVO4 Nanoparticles.

Authors:  Vassiliy A Medvedev; Ilya E Kolesnikov; Pavel K Olshin; Mikhail D Mikhailov; Alina A Manshina; Daria V Mamonova
Journal:  Materials (Basel)       Date:  2022-04-03       Impact factor: 3.623

Review 2.  Nanozymes-recent development and biomedical applications.

Authors:  Xiangyi Ren; Dongxu Chen; Yan Wang; Huifang Li; Yabing Zhang; Hongying Chen; Xi Li; Minfeng Huo
Journal:  J Nanobiotechnology       Date:  2022-02-22       Impact factor: 10.435

3.  Tumor microenvironment-activated single-atom platinum nanozyme with H2O2 self-supplement and O2-evolving for tumor-specific cascade catalysis chemodynamic and chemoradiotherapy.

Authors:  Qiqi Xu; Yuetong Zhang; Zulu Yang; Guohui Jiang; Mingzhu Lv; Huan Wang; Chenghui Liu; Jiani Xie; Chengyan Wang; Kun Guo; Zhanjun Gu; Yuan Yong
Journal:  Theranostics       Date:  2022-07-04       Impact factor: 11.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.